Xyrem
Ended Awarded
- Contract number
- 36C26123N0701
- Awardee
-
Hikma Pharmaceuticals USA Inc. UEI NQJ5E87TKNB1
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $32,487
Award facts
- Contract value 100% obligated
- $32,486.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Berkeley Heights, NJ 07922, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the delivery of the pharmaceutical product XYREM, which is a prescription medication. The contract was awarded to Hikma Pharmaceuticals USA Inc., a foreign-owned, for-profit pharmaceutical manufacturer, through a Delivery Order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract has a ceiling value of $32,486.80 and an ultimate completion date of August 29, 2023. Hikma Pharmaceuticals USA Inc. is a critical supplier of pharmaceutical products to both defense and civilian federal agencies, holding several significant federal contract Indefinite Delivery Vehicles (IDVs) with the Defense Logistics Agency (DLA) and the Department of Veterans Affairs (VA). This contract award does not have a set-aside designation.
Quick answers
Who was awarded contract 36C26123N0701?
36C26123N0701 was awarded to Hikma Pharmaceuticals USA Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on June 29, 2023.
How much is contract 36C26123N0701 worth?
The government has obligated $32,487 on 36C26123N0701.
Is contract 36C26123N0701 an order under another contract?
Yes. 36C26123N0701 is a delivery order under 36F79721D0213, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26123N0701 competed?
The extent of competition for 36C26123N0701 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award